380 related articles for article (PubMed ID: 17079196)
21. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
[TBL] [Abstract][Full Text] [Related]
22. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
24. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
25. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease.
Dogru-Abbasoglu S; Inceoglu M; Parildar-Karpuzoglu H; Hanagasi HA; Karadag B; Gurvit H; Emre M; Aykac-Toker G; Uysal M
Neurosci Lett; 2006 Sep; 404(3):258-61. PubMed ID: 16806697
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive germline mutation analysis and clinical profile in a large cohort of Brazilian xeroderma pigmentosum patients.
Santiago KM; Castro LP; Neto JPD; de Nóbrega AF; Pinto CAL; Ashton-Prolla P; Pinto E Vairo F; de Medeiros PFV; Ribeiro EM; Ribeiro BFR; do Valle FF; Doriqui MJR; Leite CHB; Rocha RM; Moura LMS; Munford V; Galante PAF; Menck CFM; Rogatto SR; Achatz MI
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2392-2401. PubMed ID: 32239545
[TBL] [Abstract][Full Text] [Related]
28. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
29. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
30. Whole Exome Sequencing of a Patient with a Milder Phenotype of Xeroderma Pigmentosum Group C.
Seo JI; Nishigori C; Ahn JJ; Ryu JY; Lee J; Lee MH; Kim SK; Jeong KH
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109656
[TBL] [Abstract][Full Text] [Related]
31. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
[TBL] [Abstract][Full Text] [Related]
32. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
[TBL] [Abstract][Full Text] [Related]
33. Micronuclei and chromosomal aberrations, important markers of ageing: possible association with XPC and XPD polymorphisms.
Kazimírová A; Barancoková M; Dzupinková Z; Wsólová L; Dusinská M
Mutat Res; 2009 Feb; 661(1-2):35-40. PubMed ID: 19027756
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal localization of three repair genes: the xeroderma pigmentosum group C gene and two human homologs of yeast RAD23.
van der Spek PJ; Smit EM; Beverloo HB; Sugasawa K; Masutani C; Hanaoka F; Hoeijmakers JH; Hagemeijer A
Genomics; 1994 Oct; 23(3):651-8. PubMed ID: 7851894
[TBL] [Abstract][Full Text] [Related]
36. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease.
Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S
Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672
[TBL] [Abstract][Full Text] [Related]
37. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk.
Khan SG; Metin A; Gozukara E; Inui H; Shahlavi T; Muniz-Medina V; Baker CC; Ueda T; Aiken JR; Schneider TD; Kraemer KH
Hum Mol Genet; 2004 Feb; 13(3):343-52. PubMed ID: 14662655
[TBL] [Abstract][Full Text] [Related]
38. Atypical Clinical Presentation of Xeroderma Pigmentosum in a Patient Harboring a Novel Missense Mutation in the XPC Gene: The Importance of Clinical Suspicion.
Meneses M; Chavez-Bourgeois M; Badenas C; Villablanca S; Aguilera P; Bennàssar A; Alos L; Puig S; Malvehy J; Carrera C
Dermatology; 2015; 231(3):217-21. PubMed ID: 26278556
[TBL] [Abstract][Full Text] [Related]
39. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Garcia-Moreno H; Langbehn DR; Abiona A; Garrood I; Fleszar Z; Manes MA; Morley AMS; Craythorne E; Mohammed S; Henshaw T; Turner S; Naik H; Bodi I; Sarkany RPE; Fassihi H; Lehmann AR; Giunti P
Brain; 2023 Dec; 146(12):5044-5059. PubMed ID: 38040034
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition.
Matakidou A; Eisen T; Fleischmann C; Bridle H; Houlston RS;
Int J Cancer; 2006 Aug; 119(4):964-7. PubMed ID: 16550608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
